Uterine Fibroid Embolization
- Uterine fibroid embolization (UFE), also called uterine artery embolization (UAE), treats symptomatic fibroids by starving them of blood instead of cutting them out.
- We thread a catheter — usually from the wrist or groin — into both uterine arteries and inject tiny particles that clog the vessels feeding the fibroids.
- Fibroids shrink and soften over weeks to months; the normal uterus has backup blood supply and recovers, so it usually keeps the organ intact.
- It's an alternative to hysterectomy or myomectomy for women who want to avoid surgery; the headline trade-off is fertility, which is why it's traditionally favored for those done having children.
- The expected aftermath is a few days of crampy pelvic pain and "post-embolization syndrome" — not a complication, just the tumors dying.
Fibroids are benign muscle tumors of the uterus, and the annoying ones can turn periods into a monthly catastrophe and press on the bladder until you've memorized every bathroom in town. The old answer was surgery. UFE offers a sneakier one: don't remove the fibroid, just cut off its lunch.
The plumbing logic
Here's the trick the whole procedure rests on. Fibroids are greedy. They recruit a dense, abnormal blood supply — far more than the surrounding healthy uterine muscle — which makes them the hungriest tissue in the neighborhood. So if you float tiny particles downstream into the uterine arteries, they get swept preferentially into the high-flow fibroid vessels and lodge there, like leaves clogging the one storm drain that's pulling the most water.
The normal uterus, meanwhile, has a more modest appetite and a backup grocery store: collateral supply from the ovarian arteries and elsewhere. So it gets briefly inconvenienced but survives, while the fibroid — wholly dependent on that one delivery route — withers. The fibroid doesn't vanish overnight; it dies, shrinks, and softens over weeks to months. Bleeding usually improves first; the bulk symptoms catch up later.
The entire procedure works because fibroids are vascular hogs. We're not aiming the particles at the fibroid — the fibroid's own greedy blood flow does the aiming for us.
Who it's for — and who it isn't
UFE is for symptomatic fibroids: heavy menstrual bleeding, pelvic pressure or bulk, and related misery — not for fibroids that just happen to show up on a scan and behave themselves. It's a genuine alternative to hysterectomy and myomectomy for women who'd rather skip the operating room and keep their uterus.
The big asterisk is fertility. The effect of UFE on future pregnancy isn't fully settled, so it has traditionally been offered to women who have completed childbearing, with myomectomy often preferred when keeping fertility is the priority. That's a shared decision, not a slogan.
Before anyone touches a catheter, you need imaging — and a pathology gut-check. A bulky uterus that looks like fibroids can occasionally be a leiomyosarcoma, a rare malignancy. Embolizing a cancer you mistook for a benign fibroid is the nightmare. Pre-procedure MRI helps characterize the fibroids and flag anything that doesn't fit the story.
A few things that argue against UFE: active pelvic infection, suspected malignancy, and pregnancy. Pedunculated subserosal fibroids (the ones dangling off the uterus on a thin stalk) are a classic caution — kill the stalk's blood supply and the fibroid can theoretically detach into the abdomen. And remember UFE treats fibroids; if the real culprit is adenomyosis, the symptom relief is a different conversation.
How it actually goes
The mechanics are the same access-and-navigate dance as any arterial embolization. We get vascular access — commonly the radial artery at the wrist or the common femoral in the groin — and steer a catheter down into the pelvis.
Then we selectively catheterize each uterine artery (yes, both — fibroids are happy to drink from either side) and inject embolic particles, typically calibrated microspheres or polyvinyl alcohol (PVA). We watch on the fluoroscopy monitor until the brisk fibroid blush fades and flow slows to a near-standstill — the visual sign the buffet is closed. Then we do the other side.
The aftermath, and the traps
The expected sequel is post-embolization syndrome: crampy pelvic pain, low-grade fever, nausea, and fatigue for a few days. This is not a complication — it's the predictable din of a dying tumor, and it's managed with pain control and reassurance. Pain peaks early and is the reason many patients stay overnight or go home with a solid analgesia plan.
Post-embolization syndrome and an actual infection can look like cousins — both bring fever and pain. The reassuring story is fever that arrives right after the procedure and steadily improves over days. Worsening pain, rising fever, or foul discharge a week or two out is a different animal and needs a real workup, not a "that's normal" shrug.
Other things to counsel about: a small chance of diminished ovarian function (those ovarian collaterals cut both ways, so particles can occasionally reach the ovaries), and the possibility that an infarcted submucosal fibroid sloughs and passes vaginally over the following weeks. Most patients see meaningful improvement in bleeding and bulk symptoms, with a minority eventually needing a repeat procedure or surgery down the line.
So the one sentence to keep: UFE doesn't fight the fibroid — it cuts the supply line and lets the tumor's own greed do it in.